Clinical Trials Directory

Trials / Unknown

UnknownNCT04915235

Prevalence and Prognosis of Cardiac Amiloidosis in Turkey

Prevalence and Prognosis of Cardiac Amiloidosis in Turkey- Registry Study

Status
Unknown
Phase
Study type
Observational
Enrollment
2,087 (estimated)
Sponsor
Turkish Society of Cardiology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis

Conditions

Interventions

TypeNameDescription
BEHAVIORALAlgorithmAlgorithm

Timeline

Start date
2020-09-18
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2021-06-07
Last updated
2021-06-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04915235. Inclusion in this directory is not an endorsement.